Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
Suresh Vedantham(Mallinckrodt (United States)), Samuel Z. Goldhaber(Harvard University), Jim A. Julian(Mallinckrodt (United States)), Susan R. Kahn(Mallinckrodt (United States)), Michael R. Jaff(Mallinckrodt (United States)), David J. Cohen(Saint Luke's Health System), Elizabeth A. Magnuson(Saint Luke's Health System), Mahmood K. Razavi(Mallinckrodt (United States)), Anthony J. Comerota(University of Michigan–Ann Arbor), Heather L. Gornik(Cleveland Clinic), Timothy P. Murphy(Brown University), Lawrence M. Lewis(Washington University in St. Louis), James R. Duncan(Mallinckrodt (United States)), Patricia Nieters(Mallinckrodt (United States)), Mary C. Derfler(Washington University in St. Louis), Marc L. Filion(Mallinckrodt (United States)), Chu-Shu Gu(Mallinckrodt (United States)), Stephen T. Kee(Mallinckrodt (United States)), Joseph R. Schneider(Central DuPage Hospital), Nael Saad(Washington University in St. Louis), Morey A. Blinder(Mallinckrodt (United States)), Stephan Moll(Mallinckrodt (United States)), David Sacks(Reading Hospital), Judith C. Lin(Henry Ford Hospital), John H. Rundback(Holy Name Medical Center), Mark J. Garcia(Christiana Hospital), Rahul Razdan(Saint Elizabeth Regional Medical Center), Eric VanderWoude(Saint Elizabeth Regional Medical Center), Vasco Marques, Clive Kearon(McMaster University)
Cited by 847Open Access
Abstract
The post-thrombotic syndrome frequently develops in patients with proximal deep-vein thrombosis despite treatment with anticoagulant therapy. Pharmacomechanical catheterdirected thrombolysis (hereafter "pharmacomechanical thrombolysis") rapidly removes thrombus and is hypothesized to reduce the risk of the post-thrombotic syndrome.
Related Papers
No related papers found
Powered by citation graph analysis